Your browser doesn't support javascript.
loading
The CRISPR-Cas system as a tool for diagnosing and treating infectious diseases.
Lou, Juan; Wang, Bin; Li, Junwei; Ni, Peng; Jin, Yuefei; Chen, Shuaiyin; Xi, Yuanlin; Zhang, Rongguang; Duan, Guangcai.
Afiliación
  • Lou J; Department of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, China.
  • Wang B; Department of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, China.
  • Li J; Department of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, China.
  • Ni P; Department of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, China.
  • Jin Y; Department of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, China.
  • Chen S; Department of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, China.
  • Xi Y; Department of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, China.
  • Zhang R; Department of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, China. zrg@zzu.edu.cn.
  • Duan G; International School of Public Health and One Health, The First Affiliated Hospital, Hainan Medical University, Haikou, China. zrg@zzu.edu.cn.
Mol Biol Rep ; 49(12): 11301-11311, 2022 Dec.
Article en En | MEDLINE | ID: mdl-35857175
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Transmisibles / Sistemas CRISPR-Cas Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Mol Biol Rep Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Transmisibles / Sistemas CRISPR-Cas Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Mol Biol Rep Año: 2022 Tipo del documento: Article País de afiliación: China